Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tidepool
Palo Alto, California, United States
- Ownership
- Private
- Employees
- ~51
- Development stage
- Other
01
Overview
Tidepool's main product, the Tidepool Loop app, received FDA clearance as the first fully interoperable automated insulin dosing app for Type 1 diabetes. The data platform and analytics products are in commercial use, and a Type 2 diabetes system (in collaboration with Embecta) is in development.[3][1][5]
- Therapeutic areas
- Endocrinology
- Modalities
- DeviceSoftware
- Industry
- Digital Health Medical Devices
02
Partnerships
EmbectaDexcomInsuletMedtronicJuvenile Diabetes Research Foundation (JDRF)Academic research collaborations
Beyond the preview
Go deeper on Tidepool.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tidepool.